NCT07837479Not yet recruiting
Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia
Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia: A Case Control Study
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Brief summary (registry, in English)
Schizophrenia is a severe and chronic psychiatric disorder that requires long-term care management, placing family members who serve as informal caregivers under substantial psychological, physical, and financial strain. While caregiver burden, anxiety, and depression are well-documented challenges in this population, psychological resilience can serve as an essential protective buffer against chronic stress. This study aims to evaluate the levels of psychological resilience and Quality of Life (QoL) among family caregivers of patients with schizophrenia compared to a matched control group of caregivers of healthy individuals. This observational case-control study will be conducted at the Neuropsychiatry Department (inpatient wards and outpatient clinics) of Assiut University Hospital in Assiut, Egypt. Primary informal caregivers aged 18 to 65 years who reside with and care for a patient clinically diagnosed with schizophrenia (DSM-5 / ICD-11 criteria) for at least 6 months will be compared to matched caregivers of healthy individuals recruited from the community. Participants will undergo structured face-to-face clinical interviews to assess: * Quality of Life: Evaluated across physical, psychological, social, and environmental domains using the World Health Organization Quality of Life Brief Version (WHOQOL-BREF). * Psychological Resilience: Measurement of individual coping ability, personal competence, and adaptability under stress. * Caregiver Burden: Quantified using the Zarit Burden Interview (ZBI). * Psychiatric Distress: Clinician-administered assessment of anxiety severity via the Hamilton Anxiety Rating Scale (HAM-A) and depressive symptoms via the Hamilton Depression Rating Scale (HAM-D). The findings aim to identify sociodemographic and clinical predictors influencing caregiver well-being and provide evidence to guide targeted psychosocial support and intervention programs.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 130 (estimated)
- First submitted
- 18 Sept 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Schizophrenia
- NCT number
- NCT07837479
What you commit to
- Study type: Observational
- Planned participants: 130
- From Oct 2026 to the primary completion date, Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Documented history of major primary psychiatric disorders (e.g., bipolar disorder, schizophrenia, organic psychosis) or severe neurological illness diagnosed prior to assuming the caregiving role.
Other illness
- Concurrently providing care for another family member suffering from a severe chronic physical disability, terminal illness, or neurodegenerative disease.
- Presence of active substance use disorders, severe cognitive impairment, or intellectual disability that impedes reliable questionnaire completion.
Other
- Refusal or inability of the caregiver to provide written informed consent.
Who the study is looking for
- Case Group (Caregivers of Patients with Schizophrenia):
- Primary informal caregiver defined as an immediate family member (parent, spouse, sibling, or adult child) providing unpaid physical, emotional, or financial assistance.
- Continuous co-residence with the patient for a minimum duration of 6 months prior to enrollment.
- Caring for an individual with an established clinical diagnosis of schizophrenia confirmed by a psychiatrist according to DSM-5 or ICD-11 criteria.
- Caregiver age between 18 and 65 years.
- Both male and female caregivers.
- Cognitive and functional ability to comprehend study instruments and complete clinical rating scales during face-to-face interviews.
- Willingness to provide voluntary written informed consent.
- Control Group:
- Family caregivers of healthy individuals with no current or past history of schizophrenia or other major psychiatric disorders.
- Matched to the case group by age, sex, marital status, educational level, and socioeconomic status.
- Willingness to provide voluntary written informed consent.
Age in the registry: 18 years to 65 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.